GE HealthCare (GEHC) announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions, the company said. The application, which is planned to be available to customers in U.S. next year, will initially focus on prostate and breast cancer, it added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare says major academic medical center adopts Hospital Pulse Tile
- GE HealthCare completes manganese-based MRI clinical development program
- GE Hlthcare Tech Inc put volume heavy and directionally bearish
- GE HealthCare price target raised to $102 from $98 at Evercore ISI
- GE HealthCare price target raised to $102 from $100 at Stifel